Insider Selling: ConvaTec Group PLC (LON:CTEC) Insider Sells £1,117,931.52 in Stock

ConvaTec Group PLC (LON:CTEC) insider Karim Bitar sold 436,692 shares of the company’s stock in a transaction on Monday, March 17th. The shares were sold at an average price of GBX 256 ($3.32), for a total transaction of £1,117,931.52 ($1,449,600.00).

Karim Bitar also recently made the following trade(s):

• On Friday, March 14th, Karim Bitar sold 132,253 shares of ConvaTec Group stock. The shares were sold at an average price of GBX 256 ($3.32), for a total transaction of £338,567.68 ($439,014.11).

ConvaTec Group Trading Up 0.4 %

Shares of CTEC opened at GBX 258.17 ($3.35) on Friday. The stock has a market capitalization of £6.57 billion, a P/E ratio of 43.48, a PEG ratio of 0.93 and a beta of 0.64. The company has a quick ratio of 0.96, a current ratio of 2.26 and a debt-to-equity ratio of 85.32. The firm has a fifty day simple moving average of GBX 247.69 and a two-hundred day simple moving average of GBX 234.80. ConvaTec Group PLC has a twelve month low of GBX 211.80 ($2.75) and a twelve month high of GBX 295.20 ($3.83).

ConvaTec Group Increases Dividend

The company also recently declared a dividend, which will be paid on Thursday, May 29th. Shareholders of record on Thursday, April 17th will be given a dividend of $0.05 per share. The ex-dividend date of this dividend is Thursday, April 17th. This represents a yield of 1.36%. This is a boost from ConvaTec Group’s previous dividend of $0.02. ConvaTec Group’s dividend payout ratio is presently 84.20%.

Wall Street Analysts Forecast Growth

Separately, Berenberg Bank reaffirmed a “buy” rating and issued a GBX 310 ($4.02) price objective on shares of ConvaTec Group in a research note on Wednesday, March 5th.

ConvaTec Group Company Profile

ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns.